This inventor holds 7 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Kyoto University, Megakaryon Corporation, Satake Multimix Corporation. Active years: 2021-2026.
Company Filing History:
7 out of 859 
7 out of 13 
1 out of 1 Years Active: 2021-2026
Title: Innovations of Yukitaka Ito in Platelet Production
Introduction
Yukitaka Ito is a prominent inventor based in Kyoto, Japan, known for his significant contributions to the field of platelet production. With a total of six patents to his name, he has made remarkable advancements that have the potential to impact medical practices related to blood disorders.
Latest Patents
Among his latest patents is a method for screening for platelet production promoters. This invention provides a systematic approach to identify candidate substances that significantly enhance the expression of TUBB1, which plays a crucial role in platelet production. Another notable patent is a method for producing platelets, which outlines a two-step process. The first step involves culturing megakaryocytes in a specialized medium that includes mechanical stress and various platelet production promoting factors. The second step focuses on harvesting the platelets produced during the culture process, ensuring that healthy and functional platelets are obtained.
Career Highlights
Yukitaka Ito has had a distinguished career, working with esteemed institutions such as Kyoto University and Megakaryon Corporation. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Yukitaka Ito has worked alongside notable colleagues, including Koji Eto and Hideya Seo. Their collaborative efforts have further advanced the understanding and production of platelets.
Conclusion
Yukitaka Ito's innovative work in platelet production and his numerous patents highlight his significant role in advancing medical science. His contributions are paving the way for new treatments and therapies in the field of hematology.